Apoptosis is a genetically encoded and meticulously controlled cellular self-destruction program, fundamental to embryogenesis, tissue equilibrium, immune function, and the removal of compromised or dangerous cells. Unlike necrosis, apoptosis unfolds via a coordinated molecular cascade that maintains the plasma membrane's integrity and avoids inciting inflammation. Mechanistically, apoptosis is driven by a family of cysteine proteases called caspases. Their activation occurs primarily through two routes: the extrinsic pathway, triggered by death receptor activation, and the intrinsic pathway, regulated by mitochondrial events. A key regulatory checkpoint of the intrinsic pathway is mitochondrial outer membrane permeabilization (MOMP), a process controlled by interactions among members of the B-cell lymphoma-2 (Bcl-2) protein family. In parallel, the inhibitor of apoptosis (IAP) proteins provides an additional regulatory layer by restraining caspase activity downstream of mitochondrial signaling. Dysregulation of these apoptotic networks is a defining feature of numerous human diseases, including cancer, autoimmune disorders, neurodegeneration, and ischemic injury. Advances in understanding apoptotic control mechanisms have facilitated the development of targeted therapeutic strategies, such as BH3-mimetics and SMAC mimetics, aimed at modulating cell death susceptibility in disease-specific contexts. This review synthesizes current insights into the molecular architecture of apoptosis, highlighting key regulatory checkpoints, pathway integration, and emerging therapeutic opportunities.
Ashkenazi, A. and Salvesen, G., 2014. Regulated cell death: signaling and mechanisms. Annual review of cell and developmental biology, 30, pp.337-356.
Aubrey, B.J., Kelly, G.L., Janic, A., Herold, M.J. and Strasser, A., 2018. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?. Cell death & differentiation, 25(1), pp.104-113.
Bock, F.J. and Tait, S.W., 2020. Mitochondria as multifaceted regulators of cell death. Nature reviews Molecular cell biology, 21(2), pp.85-100.
Carneiro, B.A. and El-Deiry, W.S., 2020. Targeting apoptosis in cancer therapy. Nature reviews Clinical oncology, 17(7), pp.395-417.
Chipuk, J.E., Moldoveanu, T., Llambi, F., Parsons, M.J. and Green, D.R., 2010. The BCL-2 family reunion. Molecular cell, 37(3), pp.299-310.
Cullen, S.P. and Martin, S.J., 2015, March. Fas and TRAIL ‘death receptors’ as initiators of inflammation: Implications for cancer. In Seminars in cell & developmental biology (Vol. 39, pp. 26-34). Academic Press.
Czabotar, P.E., Lessene, G., Strasser, A. and Adams, J.M., 2014. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nature reviews Molecular cell biology, 15(1), pp.49-63.D’ARCY, M. S. 2019. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell biology international, 43, 582–592.
Delbridge, A.R., Grabow, S., Strasser, A. and Vaux, D.L., 2016. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nature Reviews Cancer, 16(2), pp.99-109.
Doran, A.C., Yurdagul Jr, A. and Tabas, I., 2020. Efferocytosis in health and disease. Nature Reviews Immunology, 20(4), pp.254-267.
Dorstyn, L., Akey, C.W. and Kumar, S., 2018. New insights into apoptosome structure and function. Cell Death & Differentiation, 25(7), pp.1194-1208.
Dubrez, L., Berthelet, J. and Glorian, V., 2013. IAP proteins as targets for drug development in oncology. OncoTargets and therapy, pp.1285-1304.
Fuchs, Y. and Steller, H., 2015. Live to die another way: modes of programmed cell death and the signals emanating from dying cells. Nature reviews Molecular cell biology, 16(6), pp.329-344.
Galluzzi, L., Vitale, I., Aaronson, S.A., Abrams, J.M., Adam, D., Agostinis, P., Alnemri, E.S., Altucci, L., Amelio, I., Andrews, D.W. and Annicchiarico-Petruzzelli, M., 2018. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death & Differentiation, 25(3), pp.486-541.
Gong, Y., Fan, Z., Luo, G., Yang, C., Huang, Q., Fan, K., Cheng, H., Jin, K., Ni, Q., Yu, X. and Liu, C., 2019. The role of necroptosis in cancer biology and therapy. Molecular cancer, 18(1), p.100.
Guerrache, A. and Micheau, O., 2024. TNF-related apoptosis-inducing ligand: non-apoptotic signalling. Cells, 13(6), p.521.
Gyrd-Hansen, M. and Meier, P., 2010. IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer. Nature Reviews Cancer, 10(8), pp.561-574.
Horvitz, H.R., 2003. Nobel lecture: Worms, life and death. Bioscience reports, 23(5), pp.239-303.
Jan, R., 2019. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Advanced pharmaceutical bulletin, 9(2), p.205.
Julien, O. and Wells, J.A., 2017. Caspases and their substrates. Cell Death & Differentiation, 24(8), pp.1380-1389.
Kale, J., Osterlund, E.J. and Andrews, D.W., 2018. BCL-2 family proteins: changing partners in the dance towards death. Cell Death & Differentiation, 25(1), pp.65-80.
Kalkavan, H. and Green, D.R., 2018. MOMP, cell suicide as a BCL-2 family business. Cell Death & Differentiation, 25(1), pp.46-55.
Kastenhuber, E.R. and Lowe, S.W., 2017. Putting p53 in context. Cell, 170(6), pp.1062-1078.
Kerkhofs, M., Bittremieux, M., Morciano, G., Giorgi, C., Pinton, P., Parys, J.B. and Bultynck, G., 2018. Emerging molecular mechanisms in chemotherapy: Ca2+ signaling at the mitochondria-associated endoplasmic reticulum membranes. Cell death & disease, 9(3), p.334.
Kerr, J.F., Wyllie, A.H. and Currie, A.R., 1972. Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. British journal of cancer, 26(4), pp.239-257.
Kesavardhana, S., Malireddi, R.S. and Kanneganti, T.D., 2020. Caspases in cell death, inflammation, and pyroptosis. Annual review of immunology, 38(1), pp.567-595.
Kopeina, G.S., Prokhorova, E.A., Lavrik, I.N. and Zhivotovsky, B., 2018. Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way. Cell Proliferation, 51(5), p.e12467.
Kruiswijk, F., Labuschagne, C.F. and Vousden, K.H., 2015. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nature reviews Molecular cell biology, 16(7), pp.393-405.
Kvansakul, M. and Hinds, M.G., 2015. The Bcl-2 family: structures, interactions and targets for drug discovery. Apoptosis, 20(2), pp.136-150.
Lalaoui, N. and Vaux, D.L., 2018. Recent advances in understanding inhibitor of apoptosis proteins. F1000Research, 7, pp.F1000-Faculty.
McIlwain, D.R., Berger, T. and Mak, T.W., 2013. Caspase functions in cell death and disease. Cold Spring Harbor perspectives in biology, 5(4), p.a008656.
Meng, Y., Sandow, J.J., Czabotar, P.E. and Murphy, J.M., 2021. The regulation of necroptosis by post-translational modifications. Cell Death & Differentiation, 28(3), pp.861-883.
Nagata, S., 2018. Apoptosis and clearance of apoptotic cells. Annual review of immunology, 36(1), pp.489-517.
Prokhorova, E.A., Kopeina, G.S., Lavrik, I.N. and Zhivotovsky, B., 2018. Apoptosis regulation by subcellular relocation of caspases. Scientific reports, 8(1), p.12199.
Segawa, K. and Nagata, S., 2015. An apoptotic ‘eat me’signal: phosphatidylserine exposure. Trends in cell biology, 25(11), pp.639-650.
Singh, R., Letai, A. and Sarosiek, K., 2019. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nature reviews Molecular cell biology, 20(3), pp.175-193.
Strasser, A. and Vaux, D.L., 2018. Viewing BCL2 and cell death control from an evolutionary perspective. Cell Death & Differentiation, 25(1), pp.13-20.
Van Opdenbosch, N. and Lamkanfi, M., 2019. Caspases in cell death, inflammation, and disease. Immunity, 50(6), pp.1352-1364.
saedi-marghmaleki,V. and Azizi-Malekabadi,H. - (2026). Deciphering the Molecular Mechanisms of Apoptosis: Recent Advances in Controlled Cell Death Pathways. Biospeices Research, 1(1), 24-34. doi: 10.22034/bsr.2025.562124.1003
MLA
saedi-marghmaleki,V. , and Azizi-Malekabadi,H. -. "Deciphering the Molecular Mechanisms of Apoptosis: Recent Advances in Controlled Cell Death Pathways", Biospeices Research, 1, 1, 2026, 24-34. doi: 10.22034/bsr.2025.562124.1003
HARVARD
saedi-marghmaleki V., Azizi-Malekabadi H. - (2026). 'Deciphering the Molecular Mechanisms of Apoptosis: Recent Advances in Controlled Cell Death Pathways', Biospeices Research, 1(1), pp. 24-34. doi: 10.22034/bsr.2025.562124.1003
CHICAGO
V. saedi-marghmaleki and H. - Azizi-Malekabadi, "Deciphering the Molecular Mechanisms of Apoptosis: Recent Advances in Controlled Cell Death Pathways," Biospeices Research, 1 1 (2026): 24-34, doi: 10.22034/bsr.2025.562124.1003
VANCOUVER
saedi-marghmaleki V., Azizi-Malekabadi H. - Deciphering the Molecular Mechanisms of Apoptosis: Recent Advances in Controlled Cell Death Pathways. J. Biospecies Res., 2026; 1(1): 24-34. doi: 10.22034/bsr.2025.562124.1003
Biospeices Research